The notices it replaced
- Reissues: PAR-23-200 NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $774,169 in first-year total cost, median $774,169.
Most frequent study sections
- Special Emphasis Panel[ZEY1 VSN (06)]1
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Advancing the small molecule drug candidate with dual specificity as a therapy for dry AMD1R61EY036287-01 · under PAR-23-200 | CIOFFI, CHRISTOPHER L.PETRUKHIN, KONSTANTIN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $774,169 | ZEY1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.